Dermatology TextbookNormal SkinDermis

Dermal Structure and Collagens

The dermis constitutes the principal structural component of human skin, providing mechanical strength, elasticity, and a scaffold for the vascular, neural, and appendageal structures that sustain epidermal viability. Unlike the epidermis, the dermis is largely acellular, consisting primarily of extracellular matrix (ECM) produced by fibroblasts. Understanding dermal architecture at the molecular level is essential for interpreting the pathophysiology of connective tissue disorders, wound healing, and cutaneous aging. The dermis comprises approximately 70-80% collagen by dry weight, with the remainder consisting of elastic fibers, proteoglycans, and other structural proteins. This organization has been refined over millions of years to provide the optimal balance between mechanical resistance and flexibility required for the skin's barrier and protective functions.


Anatomical Organization of the Dermis

Papillary Dermis

The papillary dermis is the superficial layer immediately beneath the basement membrane zone, extending into the epidermal rete ridges as dermal papillae. This layer comprises approximately 10% of the total dermal thickness.

Structural characteristics:

  • Thin, loosely arranged collagen fibrils (primarily types I and III)
  • Fine elastic fibers (oxytalan and elaunin fibers) extending perpendicular to the DEJ
  • High vascularity: Capillary loops within dermal papillae deliver nutrients to the avascular epidermis
  • Abundant ground substance: Glycosaminoglycans and proteoglycans
  • Cellular elements: Fibroblasts, mast cells, dermal dendritic cells

Clinical correlate: The dermal papillae create the fingerprint patterns (dermatoglyphics) visible on the palmar and plantar surfaces. Lichen planus characteristically demonstrates saw-tooth (irregular) acanthosis with wedge-shaped hypergranulosis and a band-like lymphocytic infiltrate obscuring the DEJ within the papillary dermis.

Reticular Dermis

The reticular dermis constitutes approximately 90% of the total dermal thickness and extends from the papillary dermis to the subcutaneous fat.

Structural characteristics:

  • Thick, densely packed collagen bundles arranged in a basket-weave pattern
  • Mature elastic fibers oriented horizontally, interconnecting with vertical extensions
  • Fewer cells relative to ECM volume
  • Houses skin appendages: Hair follicles, sebaceous glands, eccrine/apocrine glands
  • Contains larger blood vessels and nerves

Clinical correlate: Scarring primarily involves the reticular dermis. Keloids extend beyond the original wound margins with abundant, disorganized collagen bundles. Hypertrophic scars remain within wound boundaries but show similarly excessive collagen deposition.


Collagen: Dominant ECM Component

Collagen comprises approximately 70-80% of the dry weight of the dermis. The collagen superfamily includes 29 genetically distinct types in vertebrate tissues, many of which are present in human skin.

Classification of Dermal Collagens

ClassTypesSupramolecular AssemblyKey Features
FibrillarI, III, VLarge cross-striated fibrils640 Å banding pattern, quarter-stagger array
Network-formingIV, VIIIInterlacing networkBasement membranes
MicrofibrillarVIIndependent microfibrilsAnchoring function
Anchoring fibrilVIIU-shaped anchoring fibrilsSublamina densa
TransmembraneXIII, XVIIType 2 orientationHemidesmosomes, focal adhesions
FACITIX, XII, XIV, XIX, XX, XXIFibril-associatedMolecular bridges

Type I Collagen

Type I collagen is the most abundant collagen in human dermis, accounting for approximately 80% of total dermal collagen.

Clinical appearance: Type I collagen provides skin tensile strength, resistance to stretching, and structural integrity visible clinically as normal skin texture and elasticity.

Histological characteristics: On H&E staining, Type I collagen appears as thick, eosinophilic (pink) fibers arranged in wavy bundles in the reticular dermis. With trichrome stains, Type I collagen shows blue or green coloration and exhibits parallel fiber arrangement that straightens under tension.

Dermoscopic correlation: Dense Type I collagen creates the white background color in dermoscopy, providing structural support for other dermoscopic features. In conditions affecting collagen (aging, sclerosis), dermoscopy shows altered white patterns and loss of normal structural organization.

Molecular Structure

PropertyValue
Chain composition[α1(I)]₂α2(I) — two α1 chains, one α2 chain
GenesCOL1A1 (17q21.33), COL1A2 (7q21.3)
Molecule length~300 nm
Molecular weight~285 kDa (procollagen ~450 kDa)
Triple helixGlycine-X-Y repeating sequence; glycine in every third position
Hydroxyproline content~10% of amino acids (stabilizes triple helix)
Hydroxylysine content~1% (required for cross-links)

Assembly into Fibrils

Type I collagen molecules align in a quarter-stagger array, with each molecule displaced by approximately 67 nm (one D-period) relative to its neighbor. This arrangement produces the characteristic 640 Å (64 nm) banding pattern visible by transmission electron microscopy.

The quarter-stagger array creates alternating "gap" and "overlap" zones:

  • Gap zones: Spaces between the ends of adjacent molecules (~35 nm)
  • Overlap zones: Regions where molecules overlap (~29 nm)

Clinical significance: In osteogenesis imperfecta, glycine substitutions in the triple-helical domain prevent proper helix formation. The position of the mutation along the helix correlates with severity—mutations closer to the C-terminus are more severe due to C-to-N propagation of helix formation.

Type I Collagen and Disease

DiseaseGeneMutation TypeMechanism
Osteogenesis imperfecta type ICOL1A1Null alleleHaploinsufficiency — 50% normal collagen
Osteogenesis imperfecta types II-IVCOL1A1, COL1A2Glycine substitutionsDominant-negative — abnormal molecules incorporated into fibrils
EDS arthrochalasia type (VIIA, VIIB)COL1A1, COL1A2Exon 6 skippingLoss of N-propeptide cleavage site

Type III Collagen

Type III collagen comprises approximately 10% of adult dermal collagen but is the dominant collagen during embryonic development and early wound healing.

Molecular Structure

PropertyValue
Chain composition[α1(III)]₃ — homotrimer
GeneCOL3A1 (2q32.2)
DistributionBlood vessels, GI tract, uterus, skin
Type I:III ratio~8:1 in adult dermis

Developmental Regulation

During embryonic development, type III collagen predominates. Postnatally, type I collagen synthesis accelerates, establishing the characteristic adult ratio. In wound healing, type III collagen is initially deposited in granulation tissue, then gradually replaced by type I collagen during scar maturation (remodeling phase, 6-12+ months).

Ehlers-Danlos Syndrome Vascular Type (Type IV)

The most dangerous EDS subtype — arterial, intestinal, and uterine rupture.

FeatureDetails
GeneCOL3A1
InheritanceAutosomal dominant
Mutation typesGlycine substitutions (most severe), splice-site, haploinsufficiency
MechanismDominant-negative: mutant α1(III) chains incorporate into homotrimers → structural weakness
Median survival~50 years
Cause of deathArterial rupture (especially medium-sized arteries), sigmoid perforation, uterine rupture in pregnancy
Skin findingsThin, translucent skin; visible veins; minimal wrinkling; acrogeria (aged appearance of hands/feet)
Minor criteriaEasy bruising, spontaneous pneumothorax, early-onset varicose veins

Pathognomonic clinical feature: Thin, translucent skin with visible subcutaneous vessels, particularly over the chest and abdomen.


Type V Collagen

Type V collagen represents less than 5% of total dermal collagen but plays a critical regulatory role in fibril diameter control.

Molecular Structure

PropertyValue
Chain composition[α1(V)]₂α2(V) — major form; additional α3(V) and α4(V) chains exist
GenesCOL5A1 (9q34.3), COL5A2 (2q32.2)
LocationSurface of large collagen fibrils
FunctionRegulates lateral growth of type I collagen fibrils

Fibril Diameter Regulation

Type V collagen molecules are positioned on the surface of type I/III collagen fibrils. The retained N-propeptide of α1(V) chains projects outward and sterically hinders further lateral aggregation, thus limiting fibril diameter.

In the absence of type V collagen:

  • Fibril diameters become variable and irregular
  • Cross-sections show "flower-like" morphology (irregular contours)
  • Connective tissue mechanical integrity is compromised

Ehlers-Danlos Syndrome Classic Type (Types I and II)

FeatureDetails
GenesCOL5A1 (most common), COL5A2, rarely COL1A1
InheritanceAutosomal dominant
MechanismHaploinsufficiency — 50% reduction in type V collagen production
Skin hyperextensibilitySkin extends beyond normal limits but recoils (unlike cutis laxa)
Joint hypermobilityBeighton score ≥5/9
Tissue fragility"Cigarette paper" (papyraceous) scarring, atrophic scars
Molluscoid pseudotumorsFleshy lesions over pressure points
Subcutaneous spheroidsCalcified fat lobule herniation, palpable

Skin biopsy findings: Electron microscopy demonstrates irregular collagen fibril diameters and "flower-like" cross-sections.


Type VI Collagen

Type VI collagen forms an independent microfibrillar network distinct from the large collagen fibrils.

Molecular Structure

PropertyValue
Chain compositionα1(VI)α2(VI)α3(VI) — heterotrimer with additional α4-α6 chains described
GenesCOL6A1 (21q22.3), COL6A2 (21q22.3), COL6A3 (2q37.3)
StructureShort triple helix (~105 nm) flanked by large globular domains
Supramolecular assemblyBeaded microfibrils (~105 nm periodicity)

Function

Type VI collagen microfibrils serve an anchoring function, stabilizing:

  • Collagen fibril assembly
  • Basement membrane attachment to underlying matrix
  • Cell-matrix interactions via integrin α1β1 and α2β1 binding

Clinical Correlations

Mutations in COL6A1, COL6A2, and COL6A3 cause congenital muscular dystrophies with minimal cutaneous phenotype:

  • Ullrich congenital muscular dystrophy (severe, AR)
  • Bethlem myopathy (mild, AD)

The relatively mild skin manifestations in these disorders reflect the redundancy of dermal ECM components.


Collagen Biosynthesis

Collagen synthesis is a complex, multi-step process involving intracellular post-translational modifications and extracellular processing.

Biosynthetic Pathway

Loading diagram...

Key Enzymes in Collagen Biosynthesis

EnzymeGene(s)CofactorsFunctionDisease if Deficient
Prolyl 4-hydroxylaseP4HA1, P4HA2, P4HBFe²⁺, α-KG, O₂, ascorbate4-hydroxyproline formation → helix stabilityScurvy
Lysyl hydroxylase 1PLOD1Fe²⁺, α-KG, O₂, ascorbateHydroxylysine formation → cross-linksEDS kyphoscoliotic (VI)
Lysyl hydroxylase 2PLOD2SameTelopeptide hydroxylationBruck syndrome
Lysyl hydroxylase 3PLOD3SameGlucosyltransferase activity alsoConnective tissue disorder
ADAMTS2ADAMTS2Zn²⁺N-propeptide cleavage (types I, II, III)EDS dermatosparaxis (VIIC)
BMP-1/TolloidBMP1Zn²⁺C-propeptide cleavageNot established

Prolyl Hydroxylation and Scurvy

Prolyl 4-hydroxylase catalyzes the hydroxylation of proline residues in the Y position of the Gly-X-Y sequence:

Proline + O₂ + α-ketoglutarate → 4-Hydroxyproline + CO₂ + Succinate

Ascorbic acid (vitamin C) is required to maintain the iron cofactor in its reduced (Fe²⁺) state. In scurvy (ascorbate deficiency):

  • Prolyl hydroxylation is impaired
  • Underhydroxylated collagen has lower melting temperature (Tm)
  • Triple helix is unstable at body temperature (37°C)
  • Clinical manifestations: Poor wound healing, gingival bleeding, perifollicular hemorrhages, corkscrew hairs

Collagen Cross-Linking

The tensile strength of collagen fibrils depends on covalent intermolecular cross-links formed by lysyl oxidase.

Lysyl Oxidase Family

EnzymeGeneKey Features
Lysyl oxidase (LOX)LOXClassic enzyme; requires copper cofactor
LOXL1LOXL1Exfoliation glaucoma susceptibility
LOXL2LOXL2Cancer biology, fibrosis
LOXL3LOXL3Craniofacial development
LOXL4LOXL4Cartilage

Cross-Linking Mechanism

Loading diagram...

Cross-Link Types

Cross-LinkTypeLocationStability
Dehydro-lysinonorleucineDivalentSkin, tendonImmature, reducible
Dehydro-hydroxylysinonorleucineDivalentSkin, tendonImmature, reducible
Pyridinoline (hydroxylysyl-pyridinoline)TrivalentBone, cartilage, dermisMature, non-reducible
Deoxypyridinoline (lysyl-pyridinoline)TrivalentBone, dentinMature, non-reducible

Copper Deficiency and Cross-Linking

Lysyl oxidase requires copper as a cofactor. Copper deficiency impairs cross-linking:

ConditionGeneMechanismClinical Features
Menkes syndromeATP7ADefective copper absorption → systemic copper deficiencyKinky hair, neurodegeneration, connective tissue laxity
Occipital horn syndromeATP7AAllelic, milderOccipital exostoses, bladder diverticula, skin laxity
Nutritional copper deficiencyDietaryRare; impaired wound healing
D-penicillamine toxicityCopper chelationDrug-induced cutis laxa

Collagen Degradation: Matrix Metalloproteinases

The matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that degrade ECM components.

MMP Classification

ClassMMPsPrimary Substrates
CollagenasesMMP1, MMP8, MMP13Fibrillar collagens I, II, III
GelatinasesMMP2, MMP9Gelatin, collagen IV, V, VII
StromelysinsMMP3, MMP10, MMP11Proteoglycans, laminin, collagen IV
MatrilysinsMMP7, MMP26ECM components, pro-MMPs
Membrane-typeMMP14-17, MMP24Pro-MMP2, pericellular collagenolysis

MMP1 (Interstitial Collagenase)

MMP1 is the prototypic interstitial collagenase, synthesized by fibroblasts and keratinocytes.

Cleavage specificity:

  • α1(I) chain: Cleaves at Gly⁷⁷⁵-Ile⁷⁷⁶
  • α2(I) chain: Cleaves at Gly⁷⁷⁵-Leu⁷⁷⁶

This single cleavage produces ¾ and ¼ fragments. These fragments have a lower Tm and spontaneously denature at 37°C, becoming susceptible to non-specific proteases (gelatinases).

MMP Regulation

LevelMechanism
TranscriptionalCytokines (IL-1, TNF-α), growth factors, AP-1, NF-κB
Pro-enzyme activationProteolytic cleavage of N-terminal propeptide
InhibitionTIMPs 1-4 (stoichiometric, 1:1 binding)
Pharmacological inhibitionTetracyclines (chelate Ca²⁺/Zn²⁺), synthetic inhibitors

TIMPs (Tissue Inhibitors of Metalloproteinases)

TIMPPrimary MMP TargetsKey Features
TIMP-1MMP1, MMP3, MMP9Broadly inhibitory
TIMP-2MMP2, MT-MMPsAlso required for pro-MMP2 activation
TIMP-3MMPs, ADAMs, ADAMTSsBound to ECM
TIMP-4MMP2, MT1-MMPHeart, brain

MMPs in Dermatology

ConditionMMP Involvement
PhotoagingMMP1, MMP3, MMP9 upregulated by UV → collagen degradation
Wound healingMMPs essential for keratinocyte migration, ECM remodeling
Bullous diseasesMMP9 in BP blister fluid; gelatinases in tissue separation
Tumor invasionMMP2, MMP9 facilitate basement membrane degradation
Recessive dystrophic EBLoss of collagen VII → MMP-mediated dermal fibrosis, SCC development

Osteogenesis Imperfecta: Type I Collagen Genetic Disorders

Osteogenesis imperfecta (OI) comprises a family of heritable connective tissue disorders affecting type I collagen synthesis or processing, characterized by skeletal fragility, dental abnormalities, and cutaneous features.

Molecular Classification and Mechanisms

Type I OI (90% of cases, mild):

  • Gene: COL1A1 (chromosome 17q21.33)
  • Mutation: Null allele (deletion, premature termination, splice-site mutation)
  • Pathomechanism: Haploinsufficiency — 50% reduction in type I collagen quantity with normal structure
  • Phenotype: Blue sclerae, hearing loss, bone fragility after age 30, minimal tooth involvement
  • Cutaneous findings: Normal skin appearance, no hyperextensibility

Types II-IV OI (10-30% of cases, severe):

  • Genes: COL1A1, COL1A2 (chromosome 7q21.3)
  • Mutations: Glycine substitutions in the collagenous domain
  • Pathomechanism: Dominant-negative — mutant α-chains incorporate into ~75% of collagen molecules, disrupting triple-helix formation (triple helix propagates C→N, so late mutations are worse)
  • Phenotype severity correlates with mutation location: C-terminal mutations (type II, perinatal lethal) > mid-domain mutations (type III, progressive deformity) > N-terminal mutations (type IV, mild to moderate)
  • Cutaneous findings: Type III shows hyperextensible skin similar to EDS classic, significant scarring; type IV minimal skin changes

Biochemical Consequences

Glycine substitutions disrupt the triple helix because only glycine fits in the sterically constrained interior of the helix core. Substitutions create regions of abnormal conformation, producing thermolabile triple helix (lower Tm), impaired folding, or partial incorporation into structurally weakened fibrils with irregular diameters.

Dermatopathological and Dermoscopic Features

Skin biopsy shows:

  • Normal dermal architecture in mild type I
  • Decreased dermal thickness in types III and IV
  • TEM: Irregular collagen fibril diameters, "flower-like" cross-sections in types with glycine substitutions
  • Collagen type distribution: Slightly increased type III/I ratio (normal ~0.1, OI ~0.15-0.2)

Dermoscopy shows:

  • Normal features in type I
  • Loss of structural dermoscopic patterns, increased transparency in types III and IV
  • Branching vessels may be more prominent due to thin dermis

Scurvy: Ascorbate-Dependent Collagen Defect

Scurvy results from ascorbic acid (vitamin C) deficiency, impairing collagen hydroxylation and causing profound connective tissue failure.

Molecular Pathology

Prolyl 4-hydroxylase catalyzes:

Pro-α-chain (underhydroxylated) + O₂ + α-ketoglutarate + Fe²⁺ (reduced) → Pro-α-chain (4-hydroxyproline, ~50% of Y positions) + CO₂ + succinate

Hydroxyproline stabilizes the triple helix through additional hydrogen bonding and increases melting temperature (Tm) from 24°C (unhydroxylated) to 37°C (normal, ~10% hydroxyproline). Lysine hydroxylation generates hydroxylysine, providing sites for carbohydrate attachment (glycosylation) and cross-link formation.

Ascorbate requirement: Acts as an electron donor keeping the iron cofactor in the Fe²⁺ state. Without ascorbate:

  • Iron oxidizes to Fe³⁺ (inactive)
  • Hydroxylation ceases
  • Pro-α-chains remain severely underhydroxylated (~2-3% hydroxyproline instead of 10%)
  • Underhydroxylated collagen has Tm of 24°C — denatures at body temperature
  • Fibrils become structurally incompetent → bleeding, poor wound healing, gum disease

Clinical Manifestations

  • Perifollicular hemorrhages — blood extravasates around hair follicles where dermal collagen cannot support capillaries
  • Bleeding gums (if teeth present) — gingival collagen defect
  • Poor wound healing — collagen cannot form stable fibrils to organize granulation tissue
  • Dental complications — in young children, exposed dentin hypersensitivity
  • Corkscrew hairs — defective hair shaft collagen causes characteristic appearance

Dermatopathology

Histology shows:

  • Minimal inflammation (unlike typical scurvy-mimicking vasculitis)
  • Leakage of red blood cells in dermis (perifollicular pattern)
  • Fragmented dermal collagen with poor fibril organization on TEM

Prevention and Treatment

Ascorbate requirement: ~10 mg/day minimum (RDA ~90 mg for adults). High-dose vitamin C supplementation reverses defect if caught early (weeks), though hemorrhaging scarring can be permanent.


Menkes Syndrome: Copper-Dependent Cross-Link Defect

Menkes syndrome results from mutations in ATP7A (Xq13.3, encodes a copper-transporting ATPase), causing systemic copper deficiency and cross-linking deficiency.

Molecular Mechanism

Lysyl oxidase (LOX) requires copper as a cofactor (Cu²⁺ in active site). The enzyme oxidatively deaminates lysine and hydroxylysine residues to allysine and hydroxyallysine aldehydes, initiating cross-link formation.

ATP7A mutationdefective enterocyte copper absorptionsystemic copper deficiencyLOX inactivitycollagen cross-linking failure

Clinical and Cutaneous Features

  • Kinky hair (pili torti) — defective hair shaft collagen and keratin cross-linking
  • Depigmented hair — tyrosinase (copper-dependent enzyme) deficiency reduces melanin
  • Connective tissue laxity — skin hyperextensibility (though less marked than EDS)
  • Easy bruising — fragile blood vessels
  • Neurological deterioration — cytochrome c oxidase (copper-dependent) deficiency in brain
  • Characteristic facies"cherub-like" with full cheeks
  • Death usually by age 3 years from neurological complications

Dermatopathological Features

Collagen fibrils appear immature with small diameter and poor packing due to lack of cross-links. Cross-link quantification shows severe reduction in divalent and trivalent cross-links. Cross-sectional diameters on TEM are <50 nm (normal >100 nm).

Related Disorder: Occipital Horn Syndrome

Allelic variant of Menkes (ATP7A mutations) with:

  • Milder copper deficiency (residual ATP7A function)
  • Occipital bone exostoses (benign bony bumps on occipital skull)
  • Bladder diverticula
  • Connective tissue laxity (milder than Menkes)
  • Longer survival (into adulthood)

Therapeutic Approaches

Copper supplementation or copper-histidine complex can partially restore LOX activity if started early enough, but neurological damage is often irreversible.


Ehlers-Danlos Syndromes and Related Collagen Disorders: Molecular Classification

TypeFormer NameGene(s)Protein (MW, amino acids)InheritanceMolecular DefectClinical Severity
ClassicI, IICOL5A1 (9q34.3), COL5A2 (2q32.2), COL1A1 (17q21.3)Type V collagen (~350 kDa), Type I (~285 kDa)ADHaploinsufficiency (50% reduction type V) or glycine substitutionsMild-Moderate
Classic-likeTNXB (6p21.3)Tenascin-X (~685 kDa, ECM protein)ARECM protein loss → reduced cross-linkingMild-Moderate
Cardiac ValvularCOL1A2 (7q21.3)Type I collagen α2-chainARGlycine substitutions → valve pathologyModerate
Vascular (IV)IVCOL3A1 (2q32.2)Type III collagen (~285 kDa)ADGlycine substitutions (dominant-negative) or haploinsufficiencySEVERE (50-year median)
Hypermobile (III)IIIHeterogeneous (>50% unknown)Unknown (likely ECM-related)AD (mostly)Genetic basis unclearMild (morbidity ≠ mortality)
Arthrochalasia (VIIA,VIIB)VIIA, VIIBCOL1A1, COL1A2Type I collagen (exon 6 skipping)ADN-propeptide cleavage site disrupted → unprocessed procollagenModerate
Dermatosparaxis (VIIC)VIICADAMTS2 (5q35.3)ADAMTS2 protease (593 aa, 66 kDa)ARAbsent N-propeptidase activity → no N-peptide removalModerate
Kyphoscoliotic (VI)VIPLOD1 (1q41), FKBP14 (4q22.1)LH1 (749 aa, 86 kDa), FKBP22ARHydroxylysine deficiency (PLOD1) → failed cross-linking; OR chaperone failure (FKBP14)Moderate-Severe
Brittle Cornea (IX)ZNF469, PRDM5Zinc finger protein, PRDM5ARTranscriptional regulation of collagenOcular-specific
Spondylodysplastic (X)B4GALT7 (5q14.3), B3GALT6 (12q24.31), SLC39A13 (8p21.3)Galactosyl transferase, ZIP13 zinc transporterARGAG glycosylation defect (reduced galactose) → collagen cross-link failureModerate (skeletal)
Musculocontractural (XI)CHST14 (3p21.31), DSE (6q12.1)D4ST1 sulfotransferase, dermatan sulfate epimeraseARDermatan sulfate deficiency → aberrant collagen arrangementCongenital contractures
Myopathic (XII)COL12A1 (6q12.3)Type XII collagen (FACIT, ~470 kDa)AD/ARFACIT collagen scaffold → muscle attachment dysfunctionMuscle-specific
Periodontal (VIII)VIIIC1R (12p13.31), C1S (12p13.31)Complement C1r/C1s (serine protease, 250-290 kDa)ADDefective collagen processing (complement-mediated)Periodontal-specific
Osteogenesis Imperfecta (OI)Separate disorderCOL1A1, COL1A2Type I collagenAD (mostly)Null mutations (OI type I: haploinsufficiency); glycine substitutions (OI types II-IV: dominant-negative)Skeletal-specific
Marfan SyndromeFibrillinopathyFBN1 (15q21.1)Fibrillin-1 (3,871 aa, ~350 kDa, 43 cbEGF domains)ADGlycine substitutions in cbEGF/8-Cys domains → fibrillin misfolding + defective TGF-β sequestrationVascular risk

Pathomechanical Principles

Dominant-negative mechanism (illustrated by vascular EDS):

  • Mutant COL3A1 allele produces defective α1(III) chains
  • Type III collagen is homotrimer ([α1(III)]₃)
  • With 50% mutant chains: Probability of all 3 being mutant = 0.5³ = 12.5% of trimers are all-mutant, plus 37.5% are mixed (1-2 mutant chains)
  • Mutant chains prevent proper helix formation → trimerization fails → destabilized collagen incorporated into fibrils → weak, unstable structure
  • Even single glycine substitution can cause catastrophic helix disruption

Haploinsufficiency (EDS classic):

  • 50% reduction in normal type V collagen quantity
  • Remaining normal collagen still has normal structure but insufficient quantity
  • Fibril diameters become irregular (normal ~100-300 nm, regulated by type V surface coat)
  • Result: mechanical weakness without structural abnormality in remaining collagen

Integration: Three-Language Dermal Pathology

Clinical-Pathological Correlation

Thin, translucent skin (vascular EDS, classic EDS):

  • Clinical: Skin appears semi-translucent, with visible subcutaneous vessels (especially over chest, abdomen)
  • Histopathology: Dermal thickness markedly reduced (measured on H&E), collagen fibrils on TEM show irregular diameters, poor organization
  • Dermoscopy: Loss of pigment network (due to thin dermis), prominent vascular pattern visible (subcutaneous vessels, linear or branching), loss of structural background

Atrophic ("cigarette paper") scars:

  • Clinical: Paper-thin scars with white, shiny surface, often in linear pattern
  • Histopathology: Scar tissue shows markedly reduced collagen density, sparse fibroblasts, thin epidermis overlying scarred dermis (collagen fibrils may be sparse or show abnormal organization on TEM)
  • Dermoscopy: White background (collagen), linear arrangement, loss of normal dermal network pattern

Molluscoid pseudotumors:

  • Clinical: Soft, fleshy nodules (2-5 cm) on elbows, knees, shins — result from recurrent trauma and fat hernia through damaged dermis
  • Histopathology: Subcutaneous fat protruding through defective dermal collagen, often with lipoma-like architecture, surrounding dermal fibrosis
  • Dermoscopy: Yellow background (lipid), irregular white streaks (fibrous tissue), may show surface scale or crust if overlying epidermis involved

Summary

The dermis is a precisely engineered collagen-based structure providing mechanical resilience while maintaining flexibility. Type I collagen (~80-85% of dermal collagen by dry weight) provides tensile strength; type III collagen (~10-15%) provides elasticity and is predominant in embryonic/early wound healing; type V collagen (~5%) regulates fibril diameter; type VI collagen provides microfibrillar anchoring. Elastic fibers (oxytalan → elaunin → mature fibers) scaffold with fibrillins, enabling tissue recoil. Collagen biosynthesis demands ascorbate-dependent hydroxylation of proline/lysine residues by P4H and LH enzymes, followed by triple-helix formation and secretion. Extracellular ADAMTS proteases cleave propeptides; lysyl oxidase initiates cross-linking via aldehyde chemistry, requiring copper cofactor. Mature fibrils undergo MMP-mediated remodeling, regulated by TIMP inhibitors. Genetic defects in collagen synthesis, processing, or cross-linking enzymes cause Ehlers-Danlos syndromes, each with distinct molecular mechanisms: type V/I haploinsufficiency (classic), type III glycine substitutions (vascular, most dangerous), type I exon 6 skipping (arthrochalasia, N-peptide cleavage failure), ADAMTS2 loss (dermatosparaxis, N-peptide absence), LH1 deficiency (kyphoscoliotic, hydroxylysine deficiency), plus disorders of fibrillins (Marfan), copper (Menkes), or ascorbate (scurvy). Understanding these molecular cascades enables prediction of clinical severity, genetic counseling, and potential future therapeutic targets.


This comprehensive section integrates embryological, molecular, genetic, histopathological, and dermoscopic perspectives on dermal structure, providing the foundational knowledge necessary for understanding skin pathology and connective tissue disease.

How to Cite

Cutisight. "Dermal Structure and Collagens." Encyclopedia of Dermatology [Internet]. 2026. Available from: https://cutisight.com/education/volume-02-normal-skin/part-01-embryology-anatomy-histology/06-dermis/01-dermal-structure-and-collagens

This is an open-access resource. Please cite appropriately when using in academic or clinical work.